He Q - Search Results

1

Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.

Xu F, Guo J, Wu LY, He Q, Zhang Z, Chang CK, Li X. Xu F, et al. Among authors: he q. Cytometry B Clin Cytom. 2013 Jul-Aug;84(4):267-78. doi: 10.1002/cyto.b.21089. Epub 2013 Mar 29. Cytometry B Clin Cytom. 2013. PMID: 23554290 Free article.

2

[Clinical significance of continuous karyotyping in myelodysplastic syndromes].

Lai YY, Qiu JY, Zhang Y, Zhang Y, Shi Y, He Q, Dang H, Lu DP. Lai YY, et al. Among authors: he q. Zhonghua Xue Ye Xue Za Zhi. 2004 Nov;25(11):645-8. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15634565 Chinese.

3

[Expression of insulin-like growth factor receptor type I in marrow nucleated cells from hematologic malignancies and its anti-apoptotic effect].

He Q, Li X, Tao Y, Liu YZ, Yang LP, Ying SX. He Q, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Jun;13(3):483-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005. PMID: 15972147 Chinese.

4

Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes.

Li X, Wu L, Ying S, Chang C, He Q, Pu Q. Li X, et al. Among authors: he q. Leuk Lymphoma. 2007 Jul;48(7):1353-71. doi: 10.1080/10428190701395065. Leuk Lymphoma. 2007. PMID: 17613765

5

[Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].

Li X, Wu LY, Ying SX, Chang CK, He Q, Song LQ, Pu Q. Li X, et al. Among authors: he q. Zhonghua Xue Ye Xue Za Zhi. 2007 Jul;28(7):478-83. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18072633 Chinese.

6

[Biological behavior of stromal cell-derived factor-1 on migration, adhesion and apoptosis in different kinds of AML cell lines].

Chang CK, Li X, Wu LY, Xu L, Song LX, He Q, Ying SX, Deeg J. Chang CK, et al. Among authors: he q. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Jun;16(3):461-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18549608 Chinese.

7

Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.

Wu L, Li X, Chang C, Ying S, He Q, Pu Q. Wu L, et al. Among authors: he q. Int J Lab Hematol. 2008 Oct;30(5):390-9. doi: 10.1111/j.1751-553X.2007.00970.x. Int J Lab Hematol. 2008. PMID: 19046314

8

[Efficacy of induction chemotherapy for patients with high-risk myelodysplastic syndrome (MDS) or MDS-transformed acute myeloid leukemia with CHG regimen and its comparison with regimen GAG and HA].

Su JY, Chang CK, Zhang X, Zhou LY, Song LQ, Xu L, Wu LY, He Q, Li X. Su JY, et al. Among authors: he q. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):459-63. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19379588 Clinical Trial. Chinese.

9

A delayed yet durable response to very short lenalidomide therapy and unexpected clone redistribution in a case of myelodysplastic syndrome with del(5q) and del(20q).

Xu F, Li X, Chang C, He Q, Zhang Z, Zhang Q, Wu L. Xu F, et al. Among authors: he q. Leuk Res. 2009 Nov;33(11):e199-202. doi: 10.1016/j.leukres.2009.06.009. Epub 2009 Jul 9. Leuk Res. 2009. PMID: 19592091 No abstract available.

10

Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.

Wu L, Li X, Su J, Chang C, He Q, Zhang X, Xu L, Song L, Pu Q. Wu L, et al. Among authors: he q. Leuk Lymphoma. 2009 Sep;50(9):1461-7. doi: 10.1080/10428190903096719. Leuk Lymphoma. 2009. PMID: 19672772 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,853 results

Search Page

Filters